Skip to main content
Regenerative Biomaterials logoLink to Regenerative Biomaterials
. 2021 Oct 5;8(6):rbab054. doi: 10.1093/rb/rbab054

Evaluation of the anti-biofilm activities of bacterial cellulose-tannic acid-magnesium chloride composites using an in vitro multispecies biofilm model

Wei He 1,2,#, Zhaoyu Zhang 1,#, Jing Chen 1,#, Yudong Zheng 1,, Yajie Xie 1, Wenbo Liu 1,3, Jian Wu 2,4,5, Dina A Mosselhy 6,7
PMCID: PMC8569941  PMID: 34754505

Abstract

Chronic wounds are a serious worldwide problem, which are often accompanied by wound infections. In this study, bacterial cellulose (BC)-based composites introduced with tannic acid (TA) and magnesium chloride (BC-TA-Mg) were fabricated for anti-biofilm activities. The prepared composites’ surface properties, mechanical capacity, thermal stability, water absorption and retention property, releasing behavior, anti-biofilm activities and potential cytotoxicity were tested. Results showed that TA and MgCl2 particles closely adhered to the nanofibers of BC membranes, thus increasing surface roughness and hydrophobicity of the membranes. While the introduction of TA and MgCl2 did not influence the transparency of the membranes, making it beneficial for wound inspection. BC-TA and BC-TA-Mg composites displayed increased tensile strength and elongation at break compared to pure BC. Moreover, BC-TA-Mg exhibited higher water absorption and retention capacity than BC and BC-TA, suitable for the absorption of wound exudates. BC-TA-Mg demonstrated controlled release of TA and good inhibitory effect on both singly cultured Staphylococcus aureus and Pseudomonas aeruginosa biofilm and co-cultured biofilm of S. aureus and P. aeruginosa. Furthermore, the cytotoxicity grade of BC-TA-6Mg membrane was eligible based on standard toxicity classifications. These indicated that BC-TA-Mg is potential to be used as wound dressings combating biofilms in chronic wounds.

Keywords: bacterial cellulose, tannic acid, magnesium chloride, anti-biofilm activities

Introduction

Chronic wounds are a serious worldwide problem, which bring a heavy burden to the patient and healthcare system. The wound is considered a chronic wound when the healing period is one month or more [1]. Chronic wounds mainly include diabetic foot ulcers, bedsores or pressure sores, venous leg ulcers and non-healing surgical site infections [2, 3]. In China, it has been shown that the leading cause of chronic wounds was diabetes [3]. In Europe, over 55 million patients suffered from diabetes, and 8 million of them may develop a diabetic foot ulcer. What’s worse, if the patients got poor treatment, they would progress to lower limb amputation [4]. Infection and inadequate blood supply to blood vessels can lead to chronic wounds. Infection is caused by microbial reproduction in the wound bed, resulting in prolonged inflammatory response, delayed collagen synthesis and epithelial formation, thus damaging the skin tissue [5]. Chronic infection is a persistent and progressive pathology mainly caused by inflammation around the biofilm in the body [6]. It was found that the prevalence of biofilms in acute wounds was only 6% [7], while as many as 78.2% of chronic wounds contained biofilms [8]. Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species. (i.e. ESKAPE pathogens) have been shown to be the key pathogens involved in chronic wounds infections and biofilms [9–11]. There is a consensus in the wound care community that among most wound infections, bacteria attach to wound surfaces and proliferate in the infected wound, delaying healing [12] and causing failure of treatment of wound infections [2]. Biofilms are intricate bacterial aggregates, producing an extracellular polymeric substance (EPS, a three-dimensional physical matrix formed of exopolysaccharides, lipids, proteins, and extracellular deoxyribonucleic acid, empowering bacteria with excessive resistance or tolerance against antibiotics) [13]. EPS encloses the cells, adheres to wounds, and prevents the penetration of antibiotics [9, 11].

Therefore, there is an urgent demand for novel therapeutic strategies that can defeat the bacteria and their biofilms in chronic wound infections. Bacterial cellulose (BC) is a natural polymer secreted by certain bacteria [14]. It has many unique physical, chemical, and biological properties, such as ultrafine nanofiber network, high tensile strength and elastic modulus, high water absorption and retention capacity, high crystallinity, and good biocompatibility [14, 15]. BC-based wound dressings functionalized with different antibacterial agents have been proved to be ideal materials for dealing with chronic wound infections. For example, Picolotto et al. [16] synthesized BC/red propolis composite and utilized the composite to treat diabetic mice wounds. In vivo experiments revealed that BC/red propolis accelerated wound healing of diabetic mice by inducing a decreased lesion size, less inflammation, an increase of TGF-β levels, and complete epithelization. Liu et al. [17] chemically anchored BC with quaternary ammonium salt through 2-methacryloyloxyethyl trimethylammonium chloride. The composite membrane displayed good antibacterial activities against S. aureus and Escherichia coli, and it improved healing of mouse wounds infected with E. coli. Wu et al. [18, 19] produced BC/silver nanoparticles composite, and the composite showed strong antibacterial activities. Moreover, in comparison with BC and blank control, it induced less inflammation and promoted burn wound healing in dealing with a second-degree rat scald wound. However, none of the above studies evaluated the anti-biofilm activities of the prepared materials.

In our previous work, BC-based membranes incorporated with tannic acid (TA) and magnesium chloride (BC-TA-Mg) were prepared for the purposes of antimicrobial and anti-biofilm [20]. TA is an excellent inhibitor against various bacteria [21], which could also inhibit S. aureus and P. aeruginosa biofilm formation [22]. The composites displayed a controlled release of TA, depending on the incorporated Mg2+ concentration. The released rate of TA was decreased through introducing more Mg2+ into the composites, resulting in lower cytotoxicity to L929. The BC-TA-Mg composites demonstrated intense antibacterial activities against S. aureus, P. aeruginosa and E. coli and excellent inhibition on S. aureus and P. aeruginosa biofilm formation. In our previous work, microtiter plate method was used to test the effects of the BC-TA-Mg composites on the formation of singly cultured S. aureus and P. aeruginosa biofilms [20]. However, the chronic wound environment is complex and rich in nutrients, and chronic wound infection is often associated with varieties of bacteria, both gram-positive and gram-negative species [10, 11, 23]. Therefore, it will be more meaningful to test the effects of the materials on biofilm formation of co-cultured gram-positive and gram-negative bacteria system, which is closer to a real wound environment. To achieve this, a model that can simultaneously support the growth of gram-positive and gram-negative bacteria species should be applied. Moreover, as discussed above, the material was utilized as a wound dressing to deal with chronic wounds. It will be ideal to build an in vitro artificial wound bed model to test the effects of wound dressings on biofilm formation, which is particularly important for the early-stage research and development of wound dressings. Some studies reported the development of multispecies biofilm models. However, relatively few studies reported applying in vitro models in testing the inhibitory effects of wound dressings or some other materials on biofilm formation. Hammond et al. [24] inoculated cellulose discs with burn wound bacterial isolates (S. aureus and P. aeruginosa) and then placed them on agar plates. After incubation for 24 h, a burn wound biofilm model was established. The model was then covered with antibiotic ointments-soaked gauze to check the influence of antibiotic ointments on biofilm formation. Kucera et al. [25] employed a famous ‘Lubbock chronic wound biofilm (LCWB) model’ [26] to establish multispecies (i.e. S. aureus, Enterococcusfaecalis, Bacillus subtilis and P. aeruginosa) biofilm and then moved the prepared biofilm onto an artificial wound bed. They demonstrated that this model was applicable to novel therapeutics intended for combating chronic wound biofilms.

In this study, BC-TA-Mg composites were fabricated, and surface properties, mechanical capacity, thermal stability, water absorption and retention property, releasing behavior of the prepared composite membranes were tested. Thereafter, a modified LCWB model was used to develop a multispecies biofilm, and then the biofilm was moved onto an artificial wound bed. BC-TA-Mg composites were covered on biofilm to evaluate its anti-biofilm activities. Gram staining, FITC-ConA staining and plate colony-counting method were conducted to assess the effect of BC-TA-Mg composites on the formation of biofilm of co-cultured S. aureus and P. aeruginosa. Finally, the potential cytotoxicity of prepared composites was detected. Results demonstrated that the composites were transparent and exhibited improved mechanical properties, water absorption and retention capacity compared with pure BC. Moreover, they displayed potent anti-biofilm activities, suggesting that they are potential to be used as wound dressings to treat chronic wounds. Figure 1 described the anti-biofilm activities of BC-TA-Mg composites and the anti-biofilm tests performed in this study.

Figure 1.

Figure 1.

Schematic illustration of the anti-biofilm activities of BC-TA-Mg composites and the related tests performed in this study

Materials and methods

Preparation and characterization of BC-TA-Mg composites

BC membranes, with a thickness of 3 mm and a state of hydrogel, were acquired from Hainan Yida Food Co. Ltd. (Hainan, China). BC-TA-Mg composites were prepared using the same method described in our previous work [20]. In brief, BC was first purified to remove impurities using the same approach as He et al. [27]. After purification, BC was cut into round pieces (diameter of 10 mm) and immersed in 15 ml, 4 mM TA solution. Thereafter, 15 ml MgCl2 solution in 4, 8 or 12 mM was added to the TA solution. Subsequently, 1 M NaOH solution was dropped into the mixture to adjust the pH to 6. The mixture was stirred for 10 min, and then BC-TA-Mg composites were obtained after the mixture was kept for 24 h. For BC-TA composite, no MgCl2 or NaOH solution was added.

Scanning electron microscope (SEM) was used to observe the surface morphology of BC and composite materials. Wet membranes were freeze-dried, coated with carbon layers, and then observed under SEM (Hitachi SU8020, Japan). The distribution of Mg element on the surface of the membranes was determined by an electron microprobe analyzer (EMPA, JXA-8230, JEOL, Japan).

The amount of TA loaded to BC was determined by the following formula:

Weight of TA= W1 W2

where W1 and W2 are the amounts of TA before and after BC was immersed in TA solution. W2 was measured by UV spectrophotometry. In brief, the TA solution was collected after BC membranes were taken out from the solution. The samples were washed thrice with distilled water, and the cleaning solution was also collected. TA solution and cleaning solution were mixed together, and then the absorbance at 276 nm of the mixture was tested under a UV-VIS spectrophotometer. The amount of TA contained in the mixture (W2) was determined by comparing the absorbance to the standard curve. Furthermore, the quantitative amount of Mg element contained in BC-TA-Mg composites was tested by inductively coupled plasma mass spectrometry (ICP-MS, Agilent 7500ce, USA).

The elemental composition of samples was analyzed by X-ray photoelectron spectroscopy (XPS, ESCALAB 250Xi, Thermo Scientific, USA). The survey scan of BC, BC-TA and BC-TA-6Mg and high-resolution scan of Mg 2p of BC-TA-6Mg were recorded. Aliphatic carbon (C 1s = 284.8 eV) was used to calibrate all binding energies.

Atomic force microscope (AFM, Bruker, USA) was utilized to test surface topography of the air-dried samples with a scanned area of 5.0 μm × 5.0 μm. The water contact angle of the air-dried membranes was tested using a contact angle meter (OCA20, Dataphysics Inc., Germany). The membranes were also recorded by a TENSOR II Fourier transform infrared spectroscopy (FTIR) (Bruker, Germany). A thermal analyzer (SDT Q600, TA Instruments, USA) was applied to measure the thermal properties of air-dried membranes. Membranes were heated from 30°C to 585°C in nitrogen. Tensile stress–strain properties of wet membranes were tested under a Stable Micro Systems TAHD plus Texture Analyzer. Membranes were cut into dumbbell shapes consisting with ASTM D 638-2003 Type IV specimens.

The water absorption of air-dried membranes was measured using a gravimetric method [28]. The initial dry weights of the membranes (W0) were tested. Thereafter, membranes were dipped into deionized water (with a pH of 5 and 8 adjusted by HCl and NaOH, respectively) and then kept at 37°C. After some time, the weights of membranes (Wi) were tested after water on surfaces was removed. Water absorption was determined as follows:

Water absorption=(WiW0)/W0×100%

The water retention capacity of the membranes was also tested according to our previous report [28]. The initial weights of dry membranes were measured (W0). Afterward, the samples were dipped into deionized water and then kept at 37°C for 24 h. Subsequently, water on surfaces of membranes was absorbed, and then membranes were put into centrifuge tubes. After centrifuging for 3 min (500 r/min), the weights of membranes were measured again (W1). The water retention capacity was determined by the following equation:

Water retention=(W1W0)/W0×100%

The releasing behavior of TA from BC-TA and BC-TA-Mg composites was monitored by UV spectrophotometry. Membranes were placed in a 24-well plate, and 2 ml PBS was added to each well. The samples were then put into an incubator at 37°C. After 2 h, for each sample, supernatant PBS was collected, and then 2 ml fresh PBS was added. The same operations were repeated, and supernatants at fixed intervals were obtained. The absorbance at 276 nm of the collected supernatant was measured under an UV-VIS spectrophotometer. By comparing the absorbance to that of the standard curve, the release of TA was determined. The cumulative release of TA was determined by the superposition principle.

Establishment of in vitro multispecies biofilm model

S. aureus (ATCC 23923) and P. aeruginosa (ATCC 27853) were obtained from the American Type Culture Collection. They were maintained in sterilized tryptic soy broth (TSB) medium and modified M9 medium for 24 h, respectively. Afterward, the medium was diluted to achieve a 1 × 106 CFU/ml bacterial concentration, thus obtaining the standard bacterial suspension. In vitro chronic wound biofilm was obtained by adopting a modified LCWB method according to Sun et al. [26]. In brief, 6 ml medium containing 45% TSB medium, 50% bovine plasma and 5% lysed horse blood was added into a polystyrene test tube. Then, 10 μl standard bacterial suspension was inoculated into the medium. The bacteria were incubated at 37°C with shaking (150 r/min) for 48 h.

Establishment of a biofilm on an artificial wound bed

An artificial wound bed was established according to a previous report [25]. The sterilized Luria broth base (LB) medium was poured into the petri dish to obtain a thickness of 2 mm. After the medium was solidified, a sterilized 20 mm × 8 mm polytetrafluoroethylene-coated magnetic stir bar was placed in the center of the petri dish. Then the second layer of LB medium was added, and its thickness was kept 2 mm. After the medium was completely solidified, the magnetic stir bar was carefully removed from the agar medium, resulting in an oval artificial wound bed. The preformed mature biofilm was moved with a pipette and then placed on an artificial wound bed in LB solid medium. Finally, the artificial wound bed was covered with a piece of BC-TA-Mg composite. The artificial wound bed was incubated at 37°C for 24 h. The group without covering was used as a control. After that, the biofilm was photographed and then carefully collected with a sterilized forcep and a dipper. The collected biofilm was homogenized and then used for staining and quantification of bacteria amount.

SEM observation of biofilm

The biofilm of the control group was collected for SEM observation. In brief, biofilm was rinsed with PBS and then fixed in 2.5% glutaraldehyde. Afterward, it was immersed in a series of graded ethanol (30, 50, 75, 85, 95 and 100 v/v%) for dehydration. After that, the biofilm was treated with a series of tertiary butyl alcohol (25, 50, 75 and 100 v/v%) for solvent replacement. At last, it was freeze-dried, sputtered with platinum, and then observed by SEM (GeminiSEM 300, ZEISS, Germany).

Gram staining

Briefly, a drop of sterilized water was dropped on a sterilized glass slide. Then, 10 μl bacterial biofilm was added and mixed with the water droplet on the glass slide using a pipette, forming a bacterial suspension. Therefore, the glass slide was coated with a thin layer of bacterial suspension and dried in air. Afterward, the glass slide was passed through the outer layer of the flame of the alcohol lamp three times, and the glass slide was kept on the flame for 2–3 s each time for fixation. Biofilm was stained by immersing the glass slide in 2% crystal violet for 1 min. Subsequently, the sample was rinsed with sterilized water several times and then observed under an optical microscope (DYF 800, Dianying Optics, China). The stained area of each sample was quantified based on the image data using the software Image-Pro Plus Version 6.0. The reduction rate of biofilms was calculated as the following:

Reduction rate of biofilms=(m0 m1)/m0×100%

where m0 and m1 are the amounts of stained biofilms of the control and experimental group, respectively.

FITC-ConA staining

Samples were prepared, dried and fixed as described above. After that, bacteria were fixed with paraformaldehyde (4% (w/v)), washed thrice with PBS and then dried in air. Subsequently, they were stained with 50 μg/ml FITC-ConA (Invitrogen, USA) and 1 μg/ml DAPI. After being washed thrice with PBS, samples were observed under an inverted fluorescence microscope (Zeiss, Germany). The intergraded optical density of polysaccharides and nuclei was quantified based on the image data using the software Image-Pro Plus Version 6.0. The reduction rate of intergraded optical density was calculated as the following:

Reduction rate of intergraded optical density=(n0 n1)/n0×100%

where n0 and n1 are the amounts of intergraded optical density of the control and experimental group, respectively.

Plate colony-counting method

Bacterial biofilm measuring 10 μl was taken by using a pipette and placed in a sterilized centrifuge tube. Next, 1 ml TSB medium was added into each tube, and the bacterial suspension was ultrasonically shaken for 5 min to make the bacteria evenly dispersed. The homogenized bacterial suspension was then diluted with TSB medium in a ratio of 1:10 000. Then 100 μl diluted bacterial suspension was re-inoculated in LB agar medium (for co-cultured biofilm, the medium contains particular inhibitors for S. aureus or P. aeruginosa). After incubation for 24 h, images were taken to record the number of colonies. Finally, the number of bacteria per unit volume (CFU/ml) was calculated.

In vitro cytotoxicity tests of BC-TA-Mg composites

The possible cytotoxicity of BC-TA-Mg composites on human embryonic dermal fibroblasts (CCC-ESF-1) was evaluated in vitro. Cells were purchased from the China Infrastructure of Cell Life Source. They were kept in high-glucose Dulbecco’s Modified Eagle’s medium (H-DMEM, Hyclone, USA) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin solution. The medium was refreshed every other day. Cells at passage 12 were applied in this study. Before experiments, samples were sterilized by exposure to 60Co irradiation. Afterward, the extracts of samples were obtained according to the international standard ISO 10993-12:2002. In brief, membranes were added with H-DMEM medium in 1.25 cm2/ml ratio and then incubated for 24 h. Cells were first seeded at about 30% confluency. The next day cell culture medium was replaced by the extract supplemented with 10% FBS and 1% penicillin/streptomycin solution. Cells cultured in the normal medium served as the control. To evaluate the proliferation of CCC-ESF-1, Calcein-AM (Dojindo, Japan) staining was carried out after cells were treated with extract for 1, 2 and 3 day(s). In brief, cells were washed with PBS, added with the work solution, and kept in the incubator for 15 min. After that, they were observed under an inverted fluorescence microscope (Zeiss, Germany).

Furthermore, Cell Counting Kit-8 (CCK-8, Dojindo, Japan) assay was performed to detect the potential cytotoxicity of the extract on cells. Cells were seeded and treated as described above. After incubation for 1, 2 and 3 day(s), the cell medium was changed with 110 μl normal medium containing 10 μl CCK-8. After 2 h, optical density (OD) at 450 nm was measured under a microplate reader (BioTek, USA).

Statistical analysis

IBM SPSS statistics 22 was used to analyze the data statistically. All the experiments were conducted in triplicate. One-way analysis of variance (ANOVA) followed by post hoc comparisons with the least significant difference (LSD) method was adopted, and P < 0.05 was considered statistically significant.

Results and discussion

Surface morphology and compositions of BC-TA-Mg composites

The surface morphology of membranes was displayed in Fig. 2a. BC showed a nanofiber network structure, and the orientation of nanofibers was random. As for the composite membranes, TA and MgCl2 particles were found to adhere to the nanofibers. With the increase of Mg2+ concentration, the number of attached particles increased. BC-TA-6Mg composites showed the largest number of particles attached to the nanofibers, and some of the nanofibers were even totally covered by the particles.

Figure 2.

Figure 2.

SEM images (a) and Mg elements distribution detected by EPMA (b) of BC, BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg membranes. (c) XPS survey spectra of BC, BC-TA and BC-TA-6Mg membranes. (d) High-resolution XPS spectra of Mg 1s. (e) The content of TA and Mg in different samples

Figure 2b exhibits the distribution of Mg element on different samples detected by EPMA. There was no Mg on the BC and BC-TA membranes. Mg elements were found on BC-TA-Mg membranes, and they were distributed homogeneously across the surface. Furthermore, the Mg content varied for different samples. Just as expected, BC-TA-2Mg showed the lowest content of Mg, and BC-TA-6Mg displayed the highest content of Mg. The results verified the successful introduction of TA and Mg2+ on BC.

The surface composition of BC, BC-TA and BC-TA-6Mg samples was determined by XPS. The survey spectra (Fig. 2c) revealed two major peaks at 286.7 and 533.1 eV, assigned to C 1s and O 1s, respectively. This suggested that C and O were the main elements of BC, BC-TA and BC-TA-Mg membranes. The high-resolution spectra of Mg 1s in BC-TA-6Mg composite were detected, and the fitted curve displayed a peak at 1304.80 eV, indicating the existence of MgCl2 in BC-TA-6Mg composite [29].

The content of TA and Mg in different samples was shown in Fig. 2d. BC-TA and BC-TA-Mg composites showed almost the same amount of TA (1.984 ± 0.001 mg/cm2 for BC-TA, 1.981 ± 0.003 mg/cm2 for BC-TA-2Mg, 1.978 ± 0.001 mg/cm2 for BC-TA-4Mg and 1.977 ± 0.002 mg/cm2 for BC-TA-6Mg), while the content of Mg was different for different samples. The content of Mg for BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-Mg was 0.00 ± 0.001, 1.54 ± 0.15, 2.54 ± 0.20 and 4.39 ± 0.31 ng/cm2, respectively. The results were in agreement with those detected by EPMA.

Surface roughness and surface wettability of BC-TA-Mg composites

AFM was conducted to record the surface roughness of the membranes. Figure 3a presents the three-dimensional AFM images of five different membranes, and Fig. 3c displays the histogram of Ra. All the samples revealed the nanofiber network structure. The Ra of BC-TA (24.0 ± 0.3 nm) and BC-TA-2Mg (25.5 ± 3.1 nm) was not significantly different from that of pure BC (21.4 ± 1.8 nm). However, the Ra of BC-TA-4Mg (25.5 ± 1.2 nm) and BC-TA-6Mg (31.0 ± 3.9 nm) significantly increased compared to that of pure BC. More MgCl2 particles were anchoring on the surfaces of BC nanofibers for BC-TA-4Mg and BC-TA-6Mg samples, resulting in increased Ra of the composites.

Figure 3.

Figure 3.

AFM images (a) and water contact angles images (b) of BC, BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg membranes. The inserted pictures in (b) were the photographs of five membranes. The histogram of Ra (c) and water contact angle (d) of different samples. *P < 0.05 compared with BC group, **P < 0.01 compared with BC group

Figure 3b and d exhibit surface wettability of membranes. Pure BC, with a water contact angle of 24.0 ± 3.4°, displayed high hydrophilicity, which may be attributed to large hydroxyl groups (–OH) contained in BC molecules. After the introduction of TA, the water contact angle of the membranes (25.5 ± 3.0°) was not significantly changed. Since TA molecules contain lots of phenolic hydroxyl groups, the BC-TA composite membranes also showed high hydrophilicity. The membranes got less hydrophilic when Mg2+ was incorporated into the BC matrix. As the content of Mg2+ increased, water contact angle increased from 40.0 ± 4.0° for BC-TA-2Mg to 58.9 ± 6.4° for BC-TA-6Mg. It was considered that some hydrophilic groups contained in BC-TA membranes were covered by the incorporated MgCl2 particles, resulting in decreased hydrophilicity of the composites.

The inserted pictures in Fig. 3b were the photographs of five different membranes. Pure BC was transparent, and the introduction of TA and MgCl2 did not influence the transparency of the membranes. Most BC-based membranes would become opaque after incorporating with antibacterial agents like silver nanoparticles [18] and copper nanoparticles [30], making it inconvenient for wound inspection when used as wound dressings. In comparison, the fabricated BC-TA-Mg in this study was still transparent, which was beneficial for wound inspection.

FTIR spectrum, thermal stability, mechanical properties, water absorption, water retention capacity and releasing behavior of BC-TA-Mg composites

FTIR spectrum of all the samples was shown in Fig. 4a. The FTIR spectrum of BC exhibited two characteristic peaks at 3343 and 2893 cm−1, corresponding to stretching vibration of –OH and –CH2– group, respectively [27, 30]. In addition, the peaks at 1158 and 1054 cm−1 were consistent with skeletal vibration of C–O–C pyranose ring [27, 30]. For TA, a broad adsorption between 3500 and 3000 cm−1 was detected, ascribed to the stretching vibration of phenolic group. A peak located at 1712 cm−1 was ascribed to C=O stretching, and peaks at 1615, 1536 and 1449 cm−1 corresponded to aromatic C–C stretching. Peaks at 1207 and 1034 cm−1 were associated with vibration of substituted benzene ring, and those at 1342 and 759 cm−1 were attributed to O–H vibration [20, 31, 32]. The spectrum of BC-TA and BC-TA-Mg composites displayed BC’s characteristic peaks at 3345, 2893, 1158 and 1054 cm−1. Moreover, typical peaks of TA at 1615, 1207 and 759 cm−1 were also detected on BC-TA and BC-TA-Mg composites, indicating successful introduction of TA in BC.

Figure 4.

Figure 4.

(a) FTIR spectrum of BC, BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg membranes. Weight loss (b) and derivative weight (c) of different samples. Tensile stress-strain curves (d) and histogram of tensile strength and elongation at break (e) of different samples. Water absorption capacity of different samples at pH 5 (f) and pH 8 (g). (h) Water retention rate of different samples. (i) In vitro release curve of TA from BC-TA and BC-TA-Mg composites. *P < 0.05 compared with BC group, **P < 0.01 compared with BC group

The thermal stability of pure BC and composite membranes was detected by thermogravimetric analysis test, and results are presented in Fig. 4b and c. The thermal degradation curve of all the five membranes displayed only one significant weight loss stage at 300°C to 400°C. During this stage, BC went through depolymerization and decomposition of glucosyl units [33]. It can be observed from the thermal degradation curve that the residue for different samples was different. BC showed a residue of 25.09%. The amount of residue for BC-TA membranes was lower than that of pure BC, namely 15.46%. Concerning samples containing Mg2+, the residue ranged from 22.97% for BC-TA-2Mg to 32.87% for BC-TA-6Mg, indicating that the more Mg2+ in the samples increased the membrane residue.

Figure 4d presents the tensile stress–strain curves of BC, BC-TA and BC-TA-Mg membranes. A tensile strength of 0.29 ± 0.03 MPa and an elongation at break of 73.26 ± 4.21% were reported for pure BC membranes (Fig. 4e). All the composite membranes displayed significantly higher tensile strength and elongation at break compared to pure BC membranes. BC-TA-4Mg membranes exhibited the highest tensile strength (0.61 ± 0.01 MPa), and BC-TA-6Mg membranes demonstrated the highest elongation at break (117.98 ± 7.07%) (Fig. 4e). The improved mechanical properties may be attributed to the TA and MgCl2 particles attached to BC nanofibers. As shown in Fig. 2a, TA and MgCl2 particles closely adhered to BC nanofibers, which contributed to the improved mechanical properties of the membranes. Similar phenomena have been found in BC/poly(dopamine) composite membranes [34]. The enhancement of mechanical properties promoted the flexibility and malleability of the membranes, which were beneficial for its application in biomedical fields.

Water absorption of the materials at pH 5 and pH 8, mimicking the pH of the healthy and wound skin, respectively, were tested, and the results are shown in Fig. 4f and g. At pH 5 and pH 8, all dry membranes exhibited a sharply increased water absorption ratio within the first 22 h. After that, the water absorption ratio increased gently with time. BC displayed much lower water absorption ratio compared to BC-TA and BC-TA-Mg composites. The final water absorption capacity for pure BC was quite low (452.12 ± 5.35 and 477.25 ± 18.81% at pH 5 and pH 8, respectively). As shown in Fig. 2a, the dried BC membranes displayed collapsed structure. A large number of H-bonds were contained in BC, and H-bonds tightly connected nanofibers of BC. Therefore, the dried membranes displayed smaller inner space [35], which was adverse for water molecules to enter into. Moreover, strong H-bonds stopped water molecules from breaking them. Thus less water entered into the membranes [28]. The introduction of TA and Mg2+ significantly improved the water absorption ratio of the membranes, and the more Mg2+ contained in the membranes, the higher water absorption ratio the membranes displayed. At pH 5, the water ratio was 991.33 ± 13.49%, 1036.79 ± 89.70%, 1142.76 ± 69.38% and 1434.05 ± 79.42% for BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg, respectively. At pH 8, the value for BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg was 878.52 ± 70.73%, 934.16 ± 51.84%, 945.93 ± 10.58% and 1377.74 ± 55.64%, respectively. The incorporated TA and MgCl2 particles were covered on the surfaces of the nanofibers, thus reducing the H-bonds between them [28], making it easier for water to enter into the matrix. The above data revealed that BC-TA-Mg composites exhibited strong water absorption capacity in a healthy and wound skin environment.

Figure 4h presents the water retention rate of the samples. BC-TA-4Mg (304.34 ± 25.34%) and BC-TA-6Mg (403.59 ± 58.98%) displayed higher water retention rate compared with pure BC (185.38 ± 22.58%). Ideal wound dressings with high water absorption and retention capacity are beneficial for the absorption of wound exudates. BC-TA-Mg composites displayed higher water absorption and retention capacity than BC, making it better for them to absorb wound exudates when used as wound dressings.

Figure 4i displays the release curve of TA from BC-TA and BC-TA-Mg composites. All membranes revealed a rapid release of TA during the first 2 h. The release of TA decreased gradually as time went on. Moreover, as Mg2+ concentration in the materials increased, the release of TA decreased. The results were consistent with our previous results [20], suggesting that the controlled release of TA depended on Mg2+ concentration. The incorporation of Mg2+ in BC-TA membranes conduced to the chelation of BC, TA and Mg2+, interfering with TA release [20]. Similar results have been shown by a previous study, verifying that the release of TA from carboxylated agarose composite hydrogels was decreased by ionic interaction [31]. Hydrogels containing Zn2+ cross-links displayed more TA release, while materials without Zn2+ revealed less TA release.

Establishment of a multispecies biofilm model in vitro

Few studies have investigated the interspecific relationship between S. aureus and P. aeruginosa, primarily due to the difficulty of getting the two strains to grow together under experimental conditions. Previous studies had shown that when P. aeruginosa was cultured with S. aureus in LB broth, trypsin soy broth, brain heart extract, or other media, it quickly killed S. aureus [36, 37]. Although S. aureus and P. aeruginosa could not grow together under the experimental plankton-like environments, they are usually simultaneously found in wound infections [38]. The co-presence of S. aureus and P. aeruginosa lead to disordered and delayed wound healing, thus bringing a heavier burden to patients [39].

The establishment method of multispecies biofilm model in vitro is shown in Fig. 5b, and bacteria species incubated in ordinary TSB medium (Fig. 5a) was used as control. For the control group, after incubation for 48 h, S. aureus suspension became turbid, and the primary biomass was deposited at the bottom of the test tube (Fig. 5c). As for P. aeruginosa, a pale green biofilm formed at the gas–liquid junction, and the liquid in the test tube also became cloudy (Fig. 5c). The co-culture of S. aureus and P. aeruginosa for 48 h resulted in the combination of the above two: the primary biomass of S. aureus deposited at the bottom of the test tube and a pale green biofilm of P. aeruginosa formed at the gas–liquid junction (Fig. 5c).

Figure 5.

Figure 5.

Schematic illustration for the establishment method of multispecies biofilm model in vitro: bacteria were incubated in ordinary tryptic soy broth medium (a) and modified medium (b). The formation of chronic wound biofilms in vitro: bacteria were incubated in ordinary TSB medium (c) and modified medium (d)

The modified medium consisted of lysed red blood cells, plasma, and a medium made from minced meat (TSB medium), which was used to simulate the nutrients in the wound environment. After incubation for 48 h in the modified medium, S. aureus formed a jelly-like substance, and the bacterial colonies evenly dispersed in the jelly-like gelatin (Fig. 5d). Unlike the control group, there was no biomass deposition at the bottom of the test tube. After 48 h culture, P. aeruginosa formed a pale green biofilm at the gas–liquid junction, and the liquid in the test tube remained liquid without condensation (Fig. 5d). As for the co-cultured S. aureus and P. aeruginosa, bacterial colonies of S. aureus evenly dispersed in the gel, and a pale green biofilm formed at the gas–liquid junction (Fig. 5d).

The results showed that if the inoculant contained a coagulase-positive bacterial species (e.g. S. aureus), the liquid medium would coagulate into a jelly-like substance after incubation for about 16 h (Fig. 5d). This is because S. aureus could activate the coagulation cascade through secreting staphylococcus coagulase. Staphylococcus coagulase binds to prothrombin, forming a complex named Staphylococcus thrombin. Thereafter, the complex converts soluble fibrinogen into insoluble fibrin chain [40]. P. aeruginosa could grow in this medium, but the medium does not coagulate because P. aeruginosa lacks the ability to secret coagulase, thus unable to activate the coagulation cascade. Therefore, in this study, coagulated plasma can be used as a carrier for bacterial adhesion and residence, which was considered to be more close to the actual wound environment of the human body.

In this in vitro model of multispecies biofilm, the bacterial biofilm of co-cultured S. aureus and P. aeruginosa grew, developed and matured rapidly. Furthermore, this method is easy to operate and is with low cost, thus displaying certain advantages in the field of developing chronic wound biofilm models.

Establishment of a biofilm on an artificial wound bed

As far as we know, quite a few studies reported applying in vitro model to test any materials’ anti-biofilm function. An anti-biofilm model is urgently needed to evaluate the efficiency of solid antibacterial materials. In this study, the in vitro multispecies biofilm model established by the above methods was adopted. The pre-cultured biofilm was transferred to an artificial wound bed, and the applicability of wound dressings on the model was tested as shown in Fig. 6a. Figure 6b shows that chronic wounds biofilm of S. aureus, P. aeruginosa, and co-cultured S. aureus and P. aeruginosa efficiently proliferated and matured on the artificial wound bed. This efficient proliferation and maturation demonstrated that the in vitro artificial wound bed model with a biofilm on its surface can be used to evaluate the anti-biofilm activities of wound dressings. This model is crucial for the early-stage research and development of wound dressings. Moreover, it was simple and economical to evaluate the anti-biofilm activities of any material except wound dressings.

Figure 6.

Figure 6.

(a) Schematic illustration for the establishment of biofilm on the artificial wound bed. (b) Photographs of biofilms on artificial wound bed before and after treatment with BC-TA-Mg composites for 24 h

SEM observation of biofilm

The biofilm of singly cultured S. aureus, P. aeruginosa, and co-cultured S. aureus and P. aeruginosa was observed by SEM after incubated on an artificial wound bed for 24 h. Figure 7 shows that for all the three groups, the bacterial cells were embedded with some EPS. The co-cultured strains displayed both rod-shaped P. aeruginosa and spherical S. aureus in the matrix. Besides, the biofilm was constituted of cross-linked bacterial cells and the EPS. The results were similar to a previous report [25].

Figure 7.

Figure 7.

SEM images of the biofilm model of singly cultured S. aureus, P. aeruginosa, and co-cultured S. aureus and P. aeruginosa. The images were taken at two different magnifications of 5000× and 20000×

Effects of BC-TA-Mg composites on biofilms in vitro

Figure 6b shows that singly cultured S. aureus on the artificial wound bed in the control group quickly proliferated and matured, and there were many biofilms in the middle and edge of the wound bed. The amount of biofilm formation was significantly reduced in all the experimental groups. The biomass reduction was the most significant in the BC-TA composite-treated group. In the BC-TA-2Mg and BC-TA-4Mg composite-treated group, a small number of biofilms existed in the middle and edge of the artificial wound bed. There were still some bacterial biofilms in the middle and edge of the wound bed for the BC-TA-6Mg group. The results indicate that BC-TA composite material showed the best inhibitory effect on S. aureus biofilms, followed by BC-TA-2Mg, BC-TA-4Mg and BC-6Mg in sequence.

Singly cultured P. aeruginosa on the artificial wound bed in the control group also proliferated rapidly and matured. Many of the produced biofilms presented in the middle and the edge of the wound bed, and some areas at the edge of the wound bed became significantly green, indicating a lot of pyocyanin production in the biofilms. BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg significantly inhibited biofilm production and BC-TA exhibited the best inhibitory effect.

The results were similar for the co-cultured S. aureus and P. aeruginosa with efficient proliferation and maturation in the wound bed. The edge area of the wound bed appeared to be green, suggesting the production of pyocyanin. The number of biofilms for the group treated with BC-TA was significantly reduced, followed by BC-TA-2Mg and BC-TA-4Mg treated group. For the BC-TA-6Mg treated group, there was still a tiny piece of slimy bacterial biofilms existing in the middle of the wound bed, indicating that the inhibitory effect of BC-TA-6Mg on biofilm was inferior to that of BC-TA-2Mg and BC-TA-4Mg.

Gram staining

In this study, gram staining was used to evaluate the inhibitory effect of BC-TA-Mg composite materials on bacterial biofilm formation. After gram staining, gram-positive S. aureus biofilms appeared purple, while gram-negative P. aeruginosa biofilms showed a red color. Figure 8a shows a large number of S. aureus or P. aeruginosa biofilms formed in the control group. The amount of biofilm was significantly reduced after treatment with the composite materials. A few sporadic biofilms appeared in the experimental groups, indicating that BC-TA-Mg composites displayed a good inhibitory effect on S. aureus or P. aeruginosa biofilm formation. The reduction rate of BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg against S. aureus biofilm was quantified to 95.56% ± 0.71%, 94.40% ± 1.67%, 93.92% ± 1.53% and 93.55% ± 1.85%, respectively (Fig. 8b). Besides, for P. aeruginosa biofilm, BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg showed a reduction rate of 91.96% ± 3.78%, 86.35% ± 6.98%, 74.12% ± 8.33% and 71.36% ± 7.84%, respectively (Fig. 8b).

Figure 8.

Figure 8.

(a) Gram staining for bacterial biofilm treated with different membranes for 24 h. (b) The quantified reduction rate of stained area based on image data using the software Image-Pro Plus Version 6.0. **P < 0.01 compared with the control group

When S. aureus and P. aeruginosa were co-cultured on the wound bed, a large number of P. aeruginosa biofilms were stained red and surrounded by purple S. aureus biofilms in the control group. This colored orientation confirmed that S. aureus and P. aeruginosa could be co-cultured in this modified medium, and they could proliferate and mature rapidly. After being treated with composite materials, biofilm formation was significantly reduced, and only small areas were stained purple, indicating that the number of S. aureus biofilms was higher than that of P. aeruginosa biofilms. In addition, the quantified results (Fig. 8b) show that BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg exhibited an inhibition rate of 94.94% ± 0.32%, 93.42% ± 0.33%, 92.51% ± 0.38% and 89.89% ± 0.25% against co-cultured biofilms, respectively.

FITC-ConA staining

Figure 9a shows that for the singly cultured S. aureus and P. aeruginosa, there were lots of exopolysaccharides secreted by bacteria in the control group. Treatment with composite materials significantly reduced the number of exopolysaccharides. In the BC-TA group, the amount of green fluorescence was the least. The stained area was also the smallest, suggesting that BC-TA composite material demonstrated the best inhibitory effect on the secretion of exopolysaccharides. When S. aureus and P. aeruginosa were co-cultured, the number of exopolysaccharides was significantly decreased in all the groups, demonstrating that co-culture of the two bacteria influenced the production of exopolysaccharides.

Figure 9.

Figure 9.

(a) FITC-ConA and DAPI staining for exopolysaccharides and cell nucleus of bacteria treated with different membranes for 24 h. The quantified reduction rate of intergraded optical density of FITC (b) and DAPI (c) based on image data using the software Image-Pro Plus Version 6.0. **P < 0.01 compared with control group

The integral optical density of stained polysaccharide and nucleus were quantified, and the reduction rate of integrated optical density compared with the control was calculated as displayed in Fig. 9b and c. For singly cultured S. aureus, the number of exopolysaccharides and cell nucleus was significantly decreased when the biofilms were treated with composite materials. Compared to control, the reduction rate of polysaccharide for BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg was 92.44% ± 0.68%, 89.18% ± 0.48%, 88.37% ± 0.32% and 88.27% ± 0.70%, respectively. The amount of cell nucleus decreased to 96.20% ± 0.17%, 94.54% ± 0.29%, 93.57% ± 0.38% and 92.31% ± 0.23% for BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg, respectively. P. aeruginosa showed a similar reduction in the amount of polysaccharide and cell nucleus after treatment with composite materials. BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg displayed a polysaccharide reduction rate of 91.02% ± 0.44%, 87.25% ± 2.52%, 63.25% ± 11.26% and 59.08% ± 1.00%, respectively. The reduction rate of cell nuclei for BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg was 94.40% ± 0.20%, 94.07% ± 0.46%, 93.23% ± 0.68% and 89.57% ± 1.37%, respectively. As for co-cultured S. aureus and P. aeruginosa, the amount of polysaccharide and cell nucleus also decreased when bacteria were treated with composite materials. The amount of polysaccharides of BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg treated groups decreased to 56.38% ± 2.37%, 56.08% ± 5.35%, 49.98% ± 4.43% and 43.34% ± 3.41% of control, respectively. The number of cell nucleus for BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg was 95.47% ± 0.57%, 93.61% ± 0.66%, 89.97% ± 0.98% and 88.60% ± 0.71%, respectively.

From the above data, it was concluded that BC-TA-Mg composite materials had an excellent inhibitory effect on the secretion of EPS and proliferation of singly cultured S. aureus, P. aeruginosa, and co-cultured S. aureus and P. aeruginosa. Besides, BC-TA displayed the best inhibitory activities.

Plate counting method

Plate counting method was used to evaluate the inhibition rate of BC-TA-Mg composite materials on the bacterial number in the in vitro chronic wound biofilm. The number of bacterial colonies on the agar plate can directly reflect the inhibition rate of various samples on the in vitro chronic wound biofilms. For singly cultured S. aureus, in the control group, there were a large number of colonies (7.51 × 109 ± 2.88 × 108 CFU/ml), and colonies are densely distributed on the agar plate (Fig. 10a and b). The number of colonies was largely decreased after treatment with composite materials, namely 2.87 × 107 ± 1.73 × 106, 3.16 × 107 ± 1.24 × 106, 5.23 × 107 ± 2.38 × 106 and 6.78 × 107 ± 3.93 × 106 CFU/ml for BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg, respectively (Fig. 10b). The calculated antibacterial rate for BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg was 99.62% ± 0.03%, 99.58% ± 0.02%, 99.30% ± 0.04% and 99.10% ± 0.06%, respectively (Fig. 10b). The data further confirmed that BC-TA-Mg composites exhibited excellent antibacterial activities against S. aureus, among which BC-TA had the best inhibitory effect on S. aureus biofilm formation. The materials also demonstrated strong anti-biofilm activities against singly cultured P. aeruginosa. The number of colonies for control, BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg was 3.24 × 108 ± 3.27 × 107, 1.90 × 106 ± 5.57 × 105, 2.57 × 106 ± 5.69 × 105, 7.20 × 106 ± 8.19 × 105 and 1.09 × 107 ± 1.81 × 106 CFU/ml, respectively (Fig. 10b). Besides, BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg showed an antibacterial rate of 99.41% ± 0.17%, 99.21% ± 0.18%, 97.78% ± 0.25% and 96.63% ± 0.56%, respectively (Fig. 10c). For the co-cultured S. aureus and P. aeruginosa, the inhibition percentage of BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg composites against S. aureus biofilm was 82.13% ± 1.17%, 74.58% ± 1.39%, 68.90% ± 2.34% and 61.99% ± 1.60%, respectively (Fig. 10c). The inhibition rate of BC-TA, BC-TA-2Mg, BC-TA-4Mg and BC-TA-6Mg composites against P. aeruginosa was 99.10% ± 0.13%, 97.85% ± 0.22%, 96.41% ± 0.61% and 94.94% ± 0.38%, respectively (Fig. 10c).

Figure 10.

Figure 10.

(a) Photographs of recultivated S. aureus and P. aeruginosa on agar from singly cultured biofilm or co-cultured biofilm treated with different membranes for 24 h. Number (b) and reduction rate (c) of bacteria from singly cultured biofilm or co-cultured biofilms treated with different membranes for 24 h. **P < 0.01 compared with control group

The plate counting method results demonstrated that BC-TA-Mg composite materials exhibited potent inhibitory activities on biofilm of singly cultured S. aureus, P. aeruginosa, and co-cultured S. aureus and P. aeruginosa. Moreover, BC-TA composite material remained the best inhibitory material, followed by BC-TA-2Mg, BC-TA-4Mg and BC-6Mg in sequence.

Considering the interactions between BC composites and the in vitro biofilm model, the membranes were further observed by SEM after treating the biofilm. Supplementary Fig. S1 showed that for singly cultured S. aureus, P. aeruginosa, and co-cultured S. aureus and P. aeruginosa, no bacteria or biofilm adhered or penetrated on BC-TA and BC-TA-Mg composites. Therefore, based on the results of Gram staining, FITC-ConA staining and plate counting method, it was concluded that BC-TA composite showed the best inhibitory effect on the formation of biofilms of singly cultured S. aureus, P. aeruginosa, and co-cultured S. aureus and P. aeruginosa. The introduction of Mg2+ decreased the anti-biofilm activities of the composite since it showed a more controlled TA release [20]. The results were consistent with our previous study [20]. As for singly cultured P. aeruginosa and the co-cultured system, P. aeruginosa secreted a number of phenazine compounds, including green pyocyanin [41]. Figure 5c displays that the biofilm of singly cultured P. aeruginosa and co-cultured system was pale green, suggesting the presence of pyocyanin. Pyocyanin plays essential roles in a number of significant biological activities in P. aeruginosa. It influences gene expression, and it maintains fitness of bacterial cells [42]. It is also involved in bacterial respiration. The biofilm formation of P. aeruginosa is also maintained by pyocyanin [42]. It increased the resistance of P. aeruginosa to antimicrobial agents [42]. This study found that the inhibition of BC-TA-Mg composites on singly cultured S. aureus biofilm was better than that on biofilm of singly cultured P. aeruginosa and co-cultured system (Figs. 8 and 9a and b). The reason may be that the secreted pyocyanin by P. aeruginosa increased its resistance to BC-TA-Mg composites. TA has broad-spectrum antibacterial properties, inhibiting the proliferation of microorganisms like S. aureus, P. aeruginosa and Escherichia coli [43]. TA inhibits the proliferation of bacteria by destroying the cell wall and cytoplasm of bacteria, and it also inhibits protease activities by inducing complexation with enzymes or substrates [44]. On the other hand, TA is able to chelate with metal ions, therefore it could chelate with iron ions contained in the culture medium. Microorganisms that grow under aerobic conditions need iron for conducting some essential functions, such as reducing DNA’s ribonucleotide precursor and producing heme. Therefore, the inhibitory effect of TA on bacterial growth may also be attributed to its strong ability to chelate with iron ions [45].

It has been reported that TA inhibited the formation of S. aureus biofilm, and the inhibition rate was up to 60% at 2 μM [46]. TA also shows good inhibition on P. aeruginosa biofilm [47, 48], and the inhibition efficiency depended on bacterial density and nutrient conditions [48]. Previous studies reported several possible mechanisms about the inhibitory effects of TA on bacterial biofilms. Chusri et al. [49] clarified that TA inhibited the formation of S. aureus biofilm by altering the structure of cell walls and cell surface hydrophobicity of the bacteria. Lee et al. [22] proved that anti-biofilm activities of TA might be attributed to suppressed expressions of a quorum-sensing gene (agrA), two intercellular adhesion genes (icaA and icaD) and two virulence-regulatory genes (sigB and sarA) in S. aureus. Payne et al. [46] proved that TA promoted extracellular transglycosylase IsaA levels, thus inhibiting the formation of S. aureus biofilm in multiple biofilm models. TA is a powerful quorum-sensing (QS) inhibitor, which is an anti-biofilm mechanism of TA [50, 51]. QS system is an essential channel for information communication between bacteria. Many bacterial functions such as virulence factors secretion, secondary metabolites production and biofilms maturation are regulated by this system [52]. QS inhibitors can effectively inhibit bacterial adhesion and dispersal [52]. TA inhibited QS in P. aeruginosa by suppressing N-acylhomoserine lactone synthase production, thus inhibiting biofilm formation [52]. An inhibition in EPS of P. aeruginosa by TA has also been proved to contribute to TA’s anti-biofilm activities [51]. Further investigations should be done to disclose the possible mechanism under TA’s anti-biofilm activities.

In vitro cytotoxicity of BC-TA-Mg composites

Calcein-AM staining and CCK-8 assay were conducted to evaluate the potential cytotoxicity of BC-TA-Mg composites on CCC-ESF-1. Figure 11a exhibits live cells of different groups during the three days’ incubation. On day 1, the number of live cells treated with the extracts of BC-TA and BC-TA-2Mg decreased compared with control. In comparison, BC-TA-4Mg and BC-TA-6Mg groups showed almost the same amount of live cells as control. On day 2, cell number increased for the control, BC-TA-4Mg and BC-TA-6Mg groups, and the control group displayed the most considerable amount of live cells, followed by BC-TA-6Mg, BC-TA-4Mg, BC-TA-2Mg and BC-TA in sequence. The trends almost kept the same on day 3. BC-TA group showed the smallest cell number, and BC-TA-Mg composites revealed lower cytotoxicity on CCC-ESF-1.

Figure 11.

Figure 11.

(a) Calcein-AM staining for live cells. Results of CCK-8 assay: OD values(b) and cell viability (c). *P < 0.05 compared with control group, **P < 0.01 compared with control group

Figure 11b displays the OD at 450 nm detected by CCK-8 assay, and Fig. 11c depicts cell viability calculated by normalizing OD to that of the control. On day 1, the treatment of BC-TA and BC-TA-2Mg extracts decreased cell viability to 80 ± 1% and 88 ± 2%, respectively. Treatment with extracts of BC-TA-4Mg and BC-TA-6Mg did not significantly reduce cell viability compared with control. As treatment time prolonged, cell viability decreased for all the experimental groups. Cells treated with BC-TA-6Mg extracts showed a viability of 78 ± 6% and 78 ± 0% on days 2 and 3, respectively, indicating that cells treated with BC-TA-6Mg showed stable cell viability after 2 day’s exposure. Supplementary Fig. S2 verified that cells displayed stable viability (77% ± 5%) after treatment with BC-TA-6Mg extracts for 7 days. There was no significant difference between the cell viability of the BC-TA-6Mg group on the tested three time points (day 2, 3 and 7).

The above results revealed that the released TA from the membranes displayed a certain degree of cytotoxicity to CCC-ESF-1, and the cytotoxicity of the membranes depended on the concentration of Mg2+ incorporated in the BC matrix. Previous studies also showed that the TA incorporated composites decreased viability of 3T3 fibroblast cell lines and murine RAW264.7 macrophage cells after 24 h or 48 h exposure [31, 53]. As discussed above, the incorporation of Mg2+ contributed to the controlled release of TA. The concentration of released TA decreased as the Mg2+ content increased. Therefore, cell viability increased as the Mg2+ content increased. On the other hand, BC-TA-Mg composites may also release Mg2+, and the released Mg2+ also contributed to improved cell viability as they can serve as a micronutrient for cells [54]. This study indicated that cells treated with the extracts of BC-TA-6Mg composites showed stable viability of 77–78% after 2 days’ exposure. According to the United States pharmacopeia about toxicity classification, the material was eligible when it showed cell viability of not lower than 75%. The cytotoxicity grade for the material was 0–1 [55]. Besides, BC-TA-6Mg showed significant inhibition against the biofilm of singly cultured S. aureus, P. aeruginosa, and co-cultured S. aureus and P. aeruginosa, revealing that BC-TA-6Mg composites are potential to be used as wound dressings to deal with biofilms in chronic wounds.

Conclusion

In the present study, BC-TA-Mg composite membranes were fabricated by immersing BC in TA and MgCl2 solution in sequence. SEM images showed that TA and MgCl2 particles adhered to the nanofibers of the BC matrix. EPMA results displayed that Mg elements distributed homogeneously across the surface of BC-TA-Mg membranes while no Mg was found on BC and BC-TA membranes. XPS data verified the existence of MgCl2 in the BC-TA-6Mg composite. The surface roughness and hydrophobicity of the membranes increased with the increase of Mg content. Moreover, the introduction of TA and MgCl2 did not influence the transparency of the membranes, making it beneficial for wound inspection. BC-TA and BC-TA-Mg composite membranes displayed significantly increased tensile strength and elongation at break compared to pure BC membranes. BC-TA-Mg exhibited higher water absorption and retention capacity than BC and BC-TA. Furthermore, BC-TA-Mg revealed controlled release of TA depending on the concentration of Mg2+. Gram staining, FITC-ConA staining, and plate counting method showed that BC-TA-Mg composites demonstrated excellent inhibitory activities on biofilms of singly cultured P. aeruginosa, S. aureus, and co-cultured S. aureus and P. aeruginosa. Live cells staining and CCK-8 assay proved that the cytotoxicity grade of BC-TA-6Mg was eligible. The above outcomes indicated that BC-TA-Mg composites are potential to be used as wound dressings to treat chronic wounds. More broadly, research is also needed to determine TA’s anti-biofilm activities, which is fruitful for our further work.

Supplementary Material

rbab054_Supplementary_Data

Acknowledgments

This work was financially supported by the National Natural Science Foundation of China (grant numbers 51973018, 51773018, 31700829 and 52063030), Fundamental Research Funds for the Central Universities and the Youth Teacher International Exchange & Growth Program (grant number QNXM20210019), Key Research and Development Projects of People’s Liberation Army (grant number BWS17J036), Natural Science Foundation of Jiangxi Province of China (grant number 20192ACB20033).

Supplementary data

Supplementary data are available at REGBIO online.

Conflict of interest statement. None declared.

References

  • 1. Homaeigohar S, Boccaccini AR.. Antibacterial biohybrid nanofibers for wound dressings. Acta Biomater 2020;107:25–49. [DOI] [PubMed] [Google Scholar]
  • 2. Wu Y-K, Cheng N-C, Cheng C-M.. Biofilms in chronic wounds: pathogenesis and diagnosis. Trends Biotechnol 2019;37:505–17. [DOI] [PubMed] [Google Scholar]
  • 3. Jiang Y, Huang S, Fu X. et al. Epidemiology of chronic cutaneous wounds in China. Wound Repair Regen 2011;19:181–8. [DOI] [PubMed] [Google Scholar]
  • 4. European Commission, 2014. https://cordis.europa.eu/article/id/92892-device-for-diabetic-foot-ulcers, (8 October 2021, date last accessed).
  • 5. Rondas AALM, Schols JMGA, Stobberingh EE. et al. Prevalence of chronic wounds and structural quality indicators of chronic wound care in Dutch nursing homes. Int Wound J 2015;12:630–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Hoiby N, Bjarnsholt T, Moser C. et al. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect 2015;21:S1–S25. [DOI] [PubMed] [Google Scholar]
  • 7. James GA, Swogger E, Wolcott RD. et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16:37–44. [DOI] [PubMed] [Google Scholar]
  • 8. Malone M, Bjarnsholt T, McBain AJ. et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care 2017;26:20–5. [DOI] [PubMed] [Google Scholar]
  • 9. Kadam S, Shai S, Shahane A. et al. Recent advances in non-conventional antimicrobial approaches for chronic wound biofilms: have we found the "Chink in the Armor'? Biomedicines 2019;7:35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Bowler PG, Duerden BI, Armstrong DG.. Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 2001;14:244–69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Omar A, Wright JB, Schultz G. et al. Microbial biofilms and chronic wounds. Microorganisms 2017;5:9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Metcalf DG, Bowler PG.. Clinician perceptions of wound biofilm. Int Wound J 2016;13:717–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Mosselhy DA, Assad M, Sironen T. et al. Nanotheranostics: a possible solution for drug-resistant Staphylococcus aureus and their biofilms? Nanomaterials 2021;11:82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Ahmed J, Gultekinoglu M, Edirisinghe M.. Bacterial cellulose micro-nano fibres for wound healing applications. Biotechnol Adv 2020;41:107549. [DOI] [PubMed] [Google Scholar]
  • 15. He W, Wu J, Xu J. et al. Bacterial cellulose: functional modification and wound healing applications. Adv Wound Care 2021;10:623–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Picolotto A, Pergher D, Pereira GP. et al. Bacterial cellulose membrane associated with red propolis as phytomodulator: improved healing effects in experimental models of diabetes mellitus. Biomed Pharmacother 2019;112:108640. [DOI] [PubMed] [Google Scholar]
  • 17. Liu H, Hu Y, Zhu Y. et al. A simultaneous grafting/vinyl polymerization process generates a polycationic surface for enhanced antibacterial activity of bacterial cellulose. Int J Biol Macromol 2020;143:224–34. [DOI] [PubMed] [Google Scholar]
  • 18. Wu J, Zheng Y, Song W. et al. In situ synthesis of silver-nanoparticles/bacterial cellulose composites for slow-released antimicrobial wound dressing. Carbohydr Polym 2014;102:762–771. [DOI] [PubMed] [Google Scholar]
  • 19. Wu J, Zheng Y, Wen X. et al. Silver nanoparticle/bacterial cellulose gel membranes for antibacterial wound dressing: investigation in vitro and in vivo. Biomed Mater 2014;9:035005. [DOI] [PubMed] [Google Scholar]
  • 20. Zhang Z, Sun Y, Zheng Y. et al. A biocompatible bacterial cellulose/tannic acid composite with antibacterial and anti-biofilm activities for biomedical applications. Mater Sci Eng C Mater Biol Appl 2020;106:110249. [DOI] [PubMed] [Google Scholar]
  • 21. Chung K, Wong TY, Wei C. et al. Tannins and human health: a review. Crit Rev Food Sci Nutr 1998;38:421–64. [DOI] [PubMed] [Google Scholar]
  • 22. Lee J-H, Park J-H, Cho HS. et al. Anti-biofilm activities of quercetin and tannic acid against Staphylococcus aureus. Biofouling 2013;29:491–9. [DOI] [PubMed] [Google Scholar]
  • 23. Gjodsbol K, Christensen JJ, Karlsmark T. et al. Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006;3:225–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Hammond A, Miller KG, Kruczek C. et al. An in vitro biofilm model to examine the effect of antibiotic ointments on biofilms produced by burn wound bacterial isolates. Burns 2011;37:312–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Kucera J, Sojka M, Pavlik V. et al. Multispecies biofilm in an artificial wound bed—A novel model for in vitro assessment of solid antimicrobial dressings. J Microbiol Methods 2014;103:18–24. [DOI] [PubMed] [Google Scholar]
  • 26. Sun Y, Dowd SE, Smith E. et al. In vitro multispecies Lubbock chronic wound biofilm model. Wound Repair Regen 2008;16:805–13. [DOI] [PubMed] [Google Scholar]
  • 27. He W, Zhang ZY, Zheng YD. et al. Preparation of aminoalkyl-grafted bacterial cellulose membranes with improved antimicrobial properties for biomedical applications. J Biomed Mater Res 2020;108:1086–98. [DOI] [PubMed] [Google Scholar]
  • 28. Sun Y, Meng C, Zheng Y. et al. The effects of two biocompatible plasticizers on the performance of dry bacterial cellulose membrane: a comparative study. Cellulose 2018;25:5893–908. [Google Scholar]
  • 29. Seyama H, Soma M.. X-ray photoelectron spectroscopic study of montmorillonite containing exchangeable divalent cations. J Chem Soc, Faraday Trans 1 1984;80:237–48. [Google Scholar]
  • 30. He W, Huang X, Zheng Y. et al. In situ synthesis of bacterial cellulose/copper nanoparticles composite membranes with long-term antibacterial property. J Biomater Sci Polym Ed 2018;29:2137–53. [DOI] [PubMed] [Google Scholar]
  • 31. Ninan N, Forget A, Shastri VP. et al. Antibacterial and anti-inflammatory pH-responsive tannic acid-carboxylated agarose composite hydrogels for wound healing. ACS Appl Mater Interfaces 2016;8:28511–21. [DOI] [PubMed] [Google Scholar]
  • 32. Lee HY, Hwang CH, Kim HE. et al. Enhancement of bio-stability and mechanical properties of hyaluronic acid hydrogels by tannic acid treatment. Carbohydr Polym 2018;186:290–8. [DOI] [PubMed] [Google Scholar]
  • 33. Roman M, Winter WT.. Effect of sulfate groups from sulfuric acid hydrolysis on the thermal degradation behavior of bacterial cellulose. Biomacromolecules 2004;5:1671–7. [DOI] [PubMed] [Google Scholar]
  • 34. Xie Y, Zheng Y, Fan J. et al. Novel electronic-ionic hybrid conductive composites for multifunctional flexible bioelectrode based on in situ synthesis of poly(dopamine) on bacterial cellulose. ACS Appl Mater Interfaces 2018;10:22692–702. [DOI] [PubMed] [Google Scholar]
  • 35. de Souza CF, Lucyszyn N, Woehl MA. et al. Property evaluations of dry-cast reconstituted bacterial cellulose/tamarind xyloglucan biocomposites. Carbohydr Polym 2013;93:144–53. [DOI] [PubMed] [Google Scholar]
  • 36. Palmer KL, Mashburn LM, Singh PK. et al. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 2005;187:5267–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Palmer KL, Aye LM, Whiteley M.. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum. J Bacteriol 2007;189:8079–87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Deleon S, Clinton A, Fowler H. et al. Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model. Infect Immun 2014;82:4718–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Hotterbeekx A, Kumar-Singh S, Goossens H. et al. In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. Front Cell Infect Microbiol 2017;7:106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Zajdel M, Wagrzynowicz Z, Jeljaszewicz J.. Action of staphylothrombin on bovine fibrinogen. Thromb Res 1975;6:501–10. [DOI] [PubMed] [Google Scholar]
  • 41. Ozyurek SB, Gur SD, Bilkay IS.. Production of pyocyanin pigment from Pseudomonas aeruginosa strains and investigation of the antimicrobial effect of pyocyanin on other microorganisms. Curr Opin Biotechnol 2011;22:S113. [Google Scholar]
  • 42. Jayaseelan S, Ramaswamy D, Dharmaraj S.. Pyocyanin: production, applications, challenges and new insights. World J Microbiol Biotechnol 2014;30:1159–68. [DOI] [PubMed] [Google Scholar]
  • 43. Colak SM, Yapici BM, Yapici AN.. Determination of antimicrobial activity of tannic acid in pickling process. Rom Biotechnol Lett 2010;15:5325–30. [Google Scholar]
  • 44. Akiyama H, Fujii K, Yamasaki O. et al. Antibacterial action of several tannins against Staphylococcus aureus. J Antimicrob Chemother 2001;48:487–91. [DOI] [PubMed] [Google Scholar]
  • 45. Chung KT, Lu Z, Chou MW.. Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria. Food Chem Toxicol 1998;36:1053–60. [DOI] [PubMed] [Google Scholar]
  • 46. Payne DE, Martin NR, Parzych KR. et al. Tannic acid inhibits Staphylococcus aureus surface colonization in an IsaA-dependent manner. Infect Immun 2013;81:496–504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Cho HS, Lee JH, Ryu SY. et al. Inhibition of Pseudomonas aeruginosa and Escherichia coli O157: h 7 biofilm formation by plant metabolite epsilon-viniferin. J Agric Food Chem 2013;61:7120–6. [DOI] [PubMed] [Google Scholar]
  • 48. Siddiqui MF, Rzechowicz M, Oh HS. et al. The efficacy of tannic acid in controlling biofouling by Pseudomonas aeruginosa is dependent on nutrient conditions and bacterial density. Int Biodeterior Biodegradation 2015;104:74–82. [Google Scholar]
  • 49. Chusri S, Phatthalung PN, Voravuthikunchai SP.. Anti-biofilm activity of Quercus infectoria G. Olivier against methicillin-resistant Staphylococcus aureus. Lett Appl Microbiol 2012;54:511–7. [DOI] [PubMed] [Google Scholar]
  • 50. Sarabhai S, Sharma P, Capalash N.. Ellagic acid derivatives from Terminalia chebula Retz. downregulate the expression of quorum sensing genes to attenuate Pseudomonas aeruginosa PAO1 virulence. PLoS One 2013;8:e53441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Siddiqui MF, Oh H-S, Rzechowicz M. et al. Biofouling control potential of tannic acid, ellagic acid, and epigallocatechin against Pseudomonas aeruginosa and reverse osmosis membrane multispecies community. J Ind Eng Chem 2015;30:204–11. [Google Scholar]
  • 52. Chang C, Krishnan T, Wang H. et al. Non-antibiotic quorum sensing inhibitors acting against N-acyl homoserine lactone synthase as druggable target. Sci Rep 2014;4:7245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Lomova MV, Brichkina AI, Kiryukhin MV. et al. Multilayer capsules of bovine serum albumin and tannic acid for controlled release by enzymatic degradation. ACS Appl Mater Interfaces 2015;7:11732–40. [DOI] [PubMed] [Google Scholar]
  • 54. Huang Q, Li X, Liu T. et al. Enhanced SaOS-2 cell adhesion, proliferation and differentiation on Mg-incorporated micro/nano-topographical TiO2 coatings. Appl Surface Sci 2018;447:767–76. [Google Scholar]
  • 55. USP XXII, [S] NX. Toxicity classification in US Pharmacopeia. United States Pharmacopeial Convention, Inc., USA, 1990:2069. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

rbab054_Supplementary_Data

Articles from Regenerative Biomaterials are provided here courtesy of Oxford University Press

RESOURCES